• Info
  • Insider Ownership

Insider Trading & Ownership of Matthew R. Henn

Location
Cambridge, MA
Summary
The estimated net worth of Matthew R. Henn is at least $149K dollars as of 18 Nov 2025. Matthew R. Henn is the Chief Scientific Officer and EVP of Seres Therapeutics, Inc. and owns shares of Seres Therapeutics, Inc. (MCRB) stock worth about $149K.
Signature
/s/ Thomas J. DesRosier, attorney-in-fact for Matthew R. Henn
All Insider Reports
All Insider Reports

Notify me when Matthew R. Henn files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Matthew R. Henn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MCRB Seres Therapeutics, Inc. Chief Scientific Officer and EVP $149K -$26.7K -15.2% 15 Nov 2025

Insider Transactions Reported by Matthew R. Henn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.